NEW THERAPEUTIC AGENTS MARKETED IN FIRST HALF OF 2010 P53
NOVEMBER 010 VOLUME 16, NUMBER 11
New oral agent for relapsing MS Psychiatric disorders: 340B can help FDA working to ensure medication safety 29 35
W. A A I T.
Managing your MTM practice as it grows
Brad Tice advances MTM the PharmMD way 45
A A AY